Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
Through the combination of clinical manifestations and omics, the investigators aim to explore the skin cell atlas in different stages of psoriasis lesions, establish a clinical classification standard for psoriasis, and guide the precise treatment of psoriasis.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-01-01
Completion Date
2027-12-31
Last Updated
2024-01-12
Healthy Volunteers
Yes
Conditions
Interventions
adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate
Psoriasis patients will be treated with adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors or methotrexate.
Locations (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China